vimarsana.com

Page 144 - பல்கலைக்கழகம் ஆரோக்கியம் வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson s Disease

BlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson s Disease News provided by Share this article Share this article CAMBRIDGE, Mass., April 7, 2021 /PRNewswire/ BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, announced that Health Canada has given permission to initiate Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson s Disease (PD).  This is the first trial in Canada to study pluripotent stem cell-derived dopaminergic neurons in patients with Parkinson s disease. We re excited to initiate this study with our expert collaborators at University Health Network in Toronto as we believe this trial could shift the treatment paradigm for PD patients in Canada and around the world, states Emile Nuwaysir, Ph.D., President and Chief Executive Officer of BlueRock. Our therapy is intended to replace the midbrain dopaminergic neurons lost in the

Data suggests highest risk Toronto neighbourhoods have lowest vaccination rates

Data suggests highest risk Toronto neighbourhoods have lowest vaccination rates by Michael Ranger, News Staff Posted Apr 7, 2021 6:34 am EDT Last Updated Apr 7, 2021 at 8:01 am EDT Eligible recipients get their COVID-19 vaccines at a mass vaccination clinic in Toronto on Monday, March 8, 2021. THE CANADIAN PRESS/Frank Gunn THE CANADIAN PRESS/Frank Gunn Toronto neighbourhoods that have been hardest hit by the COVID-19 pandemic also have some of the lowest vaccination rates. But according to data by ICES, broken down by postal code, the richest neighbourhoods with the lower risk rank among those where the most residents are rolling up their sleeves.

Canada s hospitals deploy artificial lungs, scramble for staff as COVID hits younger patients

Article content Younger Canadians are bearing the brunt of the nation’s latest COVID-19 surge, creating growing demand for artificial lungs and a struggle to maintain staffing in critical care units as hospitals make last-ditch efforts to save patients. Treatment with artificial lungs, known as extracorporeal membrane oxygenation, or ECMO, is much more likely to be deployed for patients under age 65, explained Marcelo Cypel, surgical director for the extracorporeal life support program at Toronto’s University Health Network (UHN). We apologize, but this video has failed to load. Try refreshing your browser, or Canada s hospitals deploy artificial lungs, scramble for staff as COVID hits younger patients Back to video

It s a significant barrier: Individuals without OHIP cards told they can t book vaccination appointments at city clinics

Published Tuesday, April 6, 2021 4:00PM EDT Last Updated Tuesday, April 6, 2021 4:53PM EDT People without a valid Ontario health card have been excluded from booking an appointment at any of Toronto’s mass vaccination clinics for the time being, a situation that at last one public health expert says is a barrier to access that we “just cannot afford” right now. Toronto’s Associate Medical Officer of Health Dr. Vinita Dubey has confirmed to CP24.com that agents at the provincial call centre are refusing to allow people without health cards to book an appointment to receive a COVID-19 vaccine at mass vaccination clinics, even though there has been no such requirement put in place by Toronto Public Health.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.